ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMA Alere Inc. Common Stock

26.68
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Alere Inc. Common Stock NYSE:IMA NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.68 0.00 01:00:00

- Current report filing (8-K)

16/07/2010 9:01pm

Edgar (US Regulatory)


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 16, 2010
Alere Inc.
(Exact name of registrant as specified in its charter)
         
Delaware   001-16789   04-3565120
(State or other jurisdiction   (Commission file number)   (IRS Employer
of incorporation)       Identification No.)
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)
Registrant’s telephone number, including area code: (781) 647-3900
Inverness Medical Innovations, Inc.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.142-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01 Other Events
Alere Inc. (the “Company”) is filing this Current Report on Form 8-K to provide the legal opinion of Jay McNamara, Esq., the Company’s Senior Counsel, Corporate & Finance, relating to the Company’s prospectus supplement filed with the SEC on June 30, 2010 (File No. 333-158542).
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
     
Exhibit No.   Description
 
5.1
  Opinion of Jay McNamara, Esq., Senior Counsel, Corporate & Finance, of the Company
 
   
23.1
  Consent of Jay McNamara, Esq., Senior Counsel, Corporate & Finance, of the Company
 
  (included in Exhibit 5.1)
 
*   furnished herewith

 


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  Alere, Inc.
 
 
  BY:   /s/ Jay McNamara    
    Jay McNamara   
    Senior Counsel — Corporate & Finance   
 
Dated: July 16, 2010

 

1 Year Alere Inc. Common Stock Chart

1 Year Alere Inc. Common Stock Chart

1 Month Alere Inc. Common Stock Chart

1 Month Alere Inc. Common Stock Chart

Your Recent History

Delayed Upgrade Clock